Chk1 phosphorylates the tumour suppressor Mig‐6, regulating the activation of EGF signalling
Ning Liu(Beijing Institute of Technology), Masatoshi Kitagawa(Hamamatsu University School of Medicine), Hiroyuki Niida(Nagoya City University), Makoto Nakanishi(The Cancer Institute Hospital), Masaki Matsumoto(Niigata University), Keiichi I. Nakayama(Tokyo Medical and Dental University), Sayuri Suzuki(Hamamatsu University School of Medicine), Kyoko Kitagawa(Hamamatsu University School of Medicine), Yojiro Kotake(Hamamatsu University School of Medicine), Senji Shirasawa(Harvard University)
Cited by 31
Related Papers
Navigating the DNA methylation landscape of cancer
|Trends in Genetics|2021|1k
Aberrant cell cycle checkpoint function and early embryonic death in <i>Chk1</i><sup>−/−</sup> mice
|Genes & Development|2000|469
Chk2‐deficient mice exhibit radioresistance and defective p53‐mediated transcription
|The EMBO Journal|2002|436